Company: LNAI
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001731122-25-000765
Chunk: 3

Company: Lunai Bioworks Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 3
---
)

NET INCOME (LOSS)
 
$
189,176

$
(58,990,070
)
 
$
(51,275,253
)
 
$
(72,694,219
)

BASIC INCOME (LOSS PER SHARE)
 
$ 
0.00

$ 
(0.54
) 
 
$ 
(0.32
) 
 
$ 
(0.91
) 

DILUTED INCOME (LOSS PER SHARE)
 
$
0.00

$
(0.54
)
 
$
(0.32
)
 
$
(0.91
)

WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING - BASIC 

 162,334,574

 109,249,637

 161,377,448

 79,754,095

WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING - DILUTED

163,930,470

109,249,637

161,377,448

79,754,095

See accompanying notes to the unaudited condensed consolidated
financial statements.

3

RENOVARO INC. AND SUBSIDIARIES 

 CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE
LOSS

(UNAUDITED)

    For the Three Months Ended 
    For the Nine Months Ended

    March 31, 
    March 31,

    2025 
    2024 
    2025 
    2024

    Net Income (Loss) 
    $189,176  
    $(58,990,070) 
    $(51,275,253) 
    $(72,694,219)
  
    Other Comprehensive Income (Loss) 

    Foreign Currency Translation, net of taxes 
     4,623,214  
     1,061,201  
     946,457  
     1,063,852 

    Comprehensive Income (Loss) 
    $4,812,390  
    $(57,928,869) 
    $(50,328,796) 
    $(71,630,367)

See accompanying notes to the unaudited condensed consolidated
financial statements.

4

RENOVARO INC. AND SUBSIDIARIES 

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’
EQUITY

(UNAUDITED)

    # of Series A Preferred Shares